Mather Group, Llc. Bridge Bio Pharma, Inc. Transaction History
Mather Group, Llc.
- $9.81 Billion
- Q3 2025
A detailed history of Mather Group, Llc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 70 shares of BBIO stock, worth $3,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70Holding current value
$3,938% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
187MCall Options Held
11.3MPut Options Held
1.91M-
Viking Global Investors LP18.6MShares$1.04 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$927 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$746 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$700 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$522 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.34B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...